RxDoctor Payments Data

Christopher Wilson, DO

Family Medicine · Pueblo, CONPI 1295797413

Payments from drug & device makers

$398in general payments, 2019–2025

Across 26 payments — averaging $15.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$63
  • Pfizer$56
  • GSK$43
  • Novo Nordisk$42
  • AstraZeneca$36
  • Johnson & Johnson$28
  • plus $130 from 6 others

What the payments were for

  • Food & beverage$38697%
  • Education$123%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$398 in reported general payments places this provider in the 65th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$104,644
Medicare patients
196
Services billed
1,239

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide66$89,420
EliquisApixaban63$68,629
RybelsusSemaglutide31$57,241
TrulicityDulaglutide30$50,232
JardianceEmpagliflozin36$47,657
FarxigaDapagliflozin Propanediol24$27,033
JanuviaSitagliptin Phosphate18$19,980
Bydureon BciseExenatide Microspheres12$10,137
LinzessLinaclotide12$9,870
Advair HfaFluticasone Propion/Salmeterol17$6,957
BelsomraSuvorexant15$6,475
Sucralfate29$6,345
Omeprazole298$4,753
Lantus SolostarInsulin Glargine,hum.Rec.Anlog20$4,629
Tresiba Flextouch U-100Insulin Degludec14$4,216

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$42$146,66297 claims
PfizerEliquis$56$68,62963 claims
Lilly USA, LLCTrulicity, Humalog$23$52,72244 claims
Boehringer IngelheimJardiance$63$47,65736 claims
AstraZenecaFarxiga$36$27,03324 claims
MerckJanuvia, Belsomra$23$26,45533 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,079 family medicine providers in Colorado.

Other family medicine in Pueblo

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →